For virologically suppressed adult patients with HIV-1. See Full Indication.
JULUCA | Innovative Pairing
An Innovative Pairing With Dolutegravir


The pairing of dolutegravir and rilpivirine inhibits the viral life cycle at 2 separate sites, like traditional 3-drug regimens
You may also be interested in

MILESTONES IN THE TREATMENT OF HIV-1


CLINICAL TRIALS


RISKS & SIDE EFFECTS

DGRWCNT200011